RxSight, Inc.

NasdaqGM:RXST 株式レポート

時価総額：US$1.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

RxSight マネジメント

マネジメント 基準チェック /34

RxSight'sの CEO はRon Kurtzで、 Jan2016年に任命され、 の在任期間は 8.58年です。 の年間総報酬は$ 3.08Mで、 20.6%給与と79.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の2.09%を直接所有しており、その価値は$ 42.02M 。経営陣と取締役会の平均在任期間はそれぞれ3.9年と3年です。

主要情報

Ron Kurtz

最高経営責任者

US$3.1m

報酬総額

CEO給与比率20.6%
CEO在任期間8.7yrs
CEOの所有権2.1%
経営陣の平均在職期間4yrs
取締役会の平均在任期間3.1yrs

経営陣の近況

Recent updates

We Think RxSight (NASDAQ:RXST) Can Easily Afford To Drive Business Growth

Sep 04
We Think RxSight (NASDAQ:RXST) Can Easily Afford To Drive Business Growth

Investing In The Future Of Cataract Surgery: The RxSight Advantage

Aug 13

With A 27% Price Drop For RxSight, Inc. (NASDAQ:RXST) You'll Still Get What You Pay For

Aug 03
With A 27% Price Drop For RxSight, Inc. (NASDAQ:RXST) You'll Still Get What You Pay For

Why RxSight, Inc. (NASDAQ:RXST) Could Be Worth Watching

Jul 12
Why RxSight, Inc. (NASDAQ:RXST) Could Be Worth Watching

RxSight: Great Business Model, Stretched Valuations

Jul 10

A Look At The Intrinsic Value Of RxSight, Inc. (NASDAQ:RXST)

Jun 20
A Look At The Intrinsic Value Of RxSight, Inc. (NASDAQ:RXST)

RxSight, Inc. (NASDAQ:RXST) Analysts Are Pretty Bullish On The Stock After Recent Results

May 09
RxSight, Inc. (NASDAQ:RXST) Analysts Are Pretty Bullish On The Stock After Recent Results

RxSight (NASDAQ:RXST) Is In A Strong Position To Grow Its Business

May 05
RxSight (NASDAQ:RXST) Is In A Strong Position To Grow Its Business

RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation

May 01

Why We're Not Concerned About RxSight, Inc.'s (NASDAQ:RXST) Share Price

Apr 16
Why We're Not Concerned About RxSight, Inc.'s (NASDAQ:RXST) Share Price

Is It Time To Consider Buying RxSight, Inc. (NASDAQ:RXST)?

Mar 24
Is It Time To Consider Buying RxSight, Inc. (NASDAQ:RXST)?

RxSight Stock: Time To Refocus Following Eye Watering Rally

Jan 16

RxSight, Inc. (NASDAQ:RXST) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Jan 09
RxSight, Inc. (NASDAQ:RXST) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

We Think RxSight (NASDAQ:RXST) Can Afford To Drive Business Growth

Dec 21
We Think RxSight (NASDAQ:RXST) Can Afford To Drive Business Growth

Revenues Tell The Story For RxSight, Inc. (NASDAQ:RXST) As Its Stock Soars 28%

Nov 24
Revenues Tell The Story For RxSight, Inc. (NASDAQ:RXST) As Its Stock Soars 28%

RxSight, Inc. (NASDAQ:RXST) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 11
RxSight, Inc. (NASDAQ:RXST) Just Reported And Analysts Have Been Lifting Their Price Targets

RxSight Non-GAAP EPS of -$0.50 beats by $0.15, revenue of $11.4M beats by $0.85M

Aug 08

RxSight says FDA requires additional info for approval of light delivery device

Jul 12

RxSight: First And Only Customizable Intraocular Lens

Aug 26

CEO報酬分析

RxSight の収益と比較して、Ron Kurtz の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$44m

Dec 31 2023US$3mUS$633k

-US$49m

Sep 30 2023n/an/a

-US$55m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$62m

Dec 31 2022US$1mUS$563k

-US$67m

Sep 30 2022n/an/a

-US$67m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$5mUS$445k

-US$49m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

US$4m

Mar 31 2021n/an/a

US$17m

Dec 31 2020US$741kUS$310k

US$3m

報酬と市場: Ronの 総報酬 ($USD 3.08M ) は、 US市場 ($USD 5.66M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Ronの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Ron Kurtz (61 yo)

8.7yrs

在職期間

US$3,081,597

報酬

Dr. Ronald M. Kurtz, also known as Ron, M.D., serves as President and Chief Executive Officer at RxSight, Inc. (formerly Calhoun Vision) since January 2016 and also serves as its Director since February 20...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Ronald Kurtz
President8.7yrsUS$3.08m2.09%
$ 40.5m
Eric Weinberg
Co-President & Chief Commercial Officer9.3yrsUS$1.65m0.77%
$ 15.0m
Shelley Thunen
Co-President & Chief Financial Officer7.6yrsUS$1.89m0.077%
$ 1.5m
Ilya Goldshleger
Co-President & Chief Operating Officer5.3yrsUS$1.89m0.11%
$ 2.1m
Rebecca Williston
Vice President of Accounting & Financeno dataデータなしデータなし
Matt Haller
Chief Technology Officerno dataデータなしデータなし
Oliver Moravcevic
Vice President of Investor Relationsless than a yearデータなしデータなし
Steve Everly
Senior VP of Sales of North Americaless than a yearデータなしデータなし
Roy Freeman
Senior VP of Marketing & Professional Relations2.7yrsデータなしデータなし
Caroline Vaughn
Vice President of Human Resources9.1yrsデータなしデータなし
Scott Gaines
Executive VP of Manufacturing & Commercial Operations2.7yrsデータなしデータなし
Maureen O'Connell
Executive VP of Clinical & Regulatory Affairs2.5yrsデータなしデータなし

4.0yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: RXSTの経営陣は 経験豊富 であると考えられます ( 3.9年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Ronald Kurtz
President8.6yrsUS$3.08m2.09%
$ 40.5m
William Link
Director7.8yrsUS$204.98k0.12%
$ 2.2m
Robert Palmisano
Independent Director3.1yrsUS$209.98k0.063%
$ 1.2m
Juliet Tammenoms Bakker
Independent Director9.3yrsUS$209.98k0.092%
$ 1.8m
Jesse Corley
Independent Chairman of the Board9.7yrsUS$257.48k1.29%
$ 25.1m
Tamara Fountain
Independent Director2.7yrsUS$204.98k0.058%
$ 1.1m
Julie Andrews
Independent Director3.1yrsUS$214.98k0.063%
$ 1.2m
Robert Warner
Independent Director3.1yrsUS$212.48k0.063%
$ 1.2m
Shweta Maniar
Independent Director2.8yrsUS$199.98k0.014%
$ 280.2k

3.1yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: RXSTの 取締役会 は 経験豊富 であると考えられます ( 3年の平均在任期間)。